Edition:
India

People: ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

53.84USD
23 Nov 2020
Change (% chg)

-- (--)
Prev Close
$53.84
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
451,040
52-wk High
$58.67
52-wk Low
$30.02

Kim, Austin 

Mr. Austin D. Kim is Executive Vice President, General Counsel, and Secretary of the Company. He is our Executive Vice President, General Counsel, and Secretary and has been with our company since July 2018. From 2006 until 2017, Mr. Kim held several senior legal positions at Teva Pharmaceuticals, a global specialty pharmaceutical company. At Teva, Mr. Kim was most recently Vice President and Deputy General Counsel, Corporate/M&A, handling corporate and securities law matters, acquisitions and corporate development, capital markets transactions and corporate governance matters. Before joining Teva, Mr. Kim was Deputy General Counsel at IVAX Corporation, a global generic pharmaceutical company, which was acquired by Teva in 2006. Earlier in his career, Mr. Kim was a senior lawyer at Transamerica Corporation, practiced law at Pillsbury, Madison & Sutro and clerked for Judge Vaughn Walker of the United States District Court, Northern District of California. Mr. Kim received his J.D. from Columbia University School of Law and his A.B. in English literature and economics from Stanford University.

Basic Compensation

Total Annual Compensation, USD 435,913
Restricted Stock Award, USD 603,835
Long-Term Incentive Plans, USD --
All Other, USD 866,379
Fiscal Year Total, USD 1,906,130

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 17,500 480,900.00
Name Fiscal Year Total

Stephen Biggar

319,959

Srdjan Stankovic

5,088,270

Stephen Davis

7,631,250

Elena Ridloff

1,990,870

Austin Kim

1,906,130

Gudarz Davar

--
As Of  31 Dec 2019